VANCOUVER, British Columbia, June 18, 2021 (GLOBE NEWSWIRE) – KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American leader in mental health treatment and related research, is pleased to announce that it has recently hired a small number of service providers without at arm’s length to help with investor relations, media and public awareness.

First, CanaComGroup (“GCC“) was engaged to provide an investor outreach program to engage with the online community and help better understand Ketamine One (“CCG Services“) for a period of six months, subject to the terms of the service contract (the”GCC Agreement») Concluded between MEDI and GCC. Pursuant to the CCG Agreement, the CCG will receive an initial cash amount of $ 50,000 plus Goods and Services Tax (“GST“) for CCG Services to be provided over a period of six months.

Second, the Company engaged CFN Enterprises Inc. (“CFN Media“), to provide investor relations and media services (the”RCF Media Services“) for an initial period of three months, subject to the terms of the service contract (the”CFN media agreement») Concluded between MEDI and CFN Media. Pursuant to the terms of the agreement with CFN Media, CFN Media will receive cumulative cash compensation of US $ 27,000 over the three-month term. For more information on CFN Media, please visit https://www.cannabisfn.com/.

Third, the Company has engaged Proactive Investors North America Inc. (“Proactive“), to help the Company improve its online profile with the global investment community (the”Proactive services“) for a period of thirteen months, subject to the terms of the service contract (the”Proactive agreement“) entered into between the Company and Proactive. Pursuant to the terms of the Proactive Agreement, Proactive will receive an initial cash amount of $ 25,000 plus GST for proactive services to be provided over the 13-month term.

The Company also announces that subject to acceptance by the NEO Exchange, it has granted a total of 50,000 stock options (the “”Options”) A director to purchase up to 50,000 common shares of the Company at a price of $ 1.70 per common share for a period of five years from the date of grant, in accordance with his plan of stock options which was approved by the shareholders on February 21, 2021. 50% of the options vest six months after the grant date and the remaining 50% of the options vest twelve months after the grant date. attribution.

ABOUT KETAMINE ONE

KetamineOne Capital Limited (formerly Myconic Capital Corp.) (NEO: MEDI) is a company focused on consolidating medical clinics and becoming a North American leader in mental health treatment. It strives to provide the essential infrastructure needed to develop and deliver breakthrough mental health treatments. Currently, Ketamine One has a network of 15 clinics across North America, with plans to further consolidate the highly fragmented industry. The recent addition of KGK Science Inc. as the contract research division of the company also places the company at the forefront of high-end clinical research based on its 23-year history and extensive experience in the pharmaceutical, cannabis and emerging psychedelic medicine industries. As a collective enterprise, Ketamine One is dedicated to helping address the growing need for safe and accessible mental health therapy.

On behalf of:

KETAMINE ONE

“Robert meister“
Robert Meister, CEO and Director

For more information, please contact:

Nick Kuzyk, Investor Relations
Tel: 1-844-PHONE-K1 (1-844-746-6351)
Email: [email protected]
The Web: www.ketamine.one
Twitter: @KetamineOne

Notice regarding forward-looking information:

This press release contains forward-looking statements, including, but not limited to, statements regarding the business, assets or investments of the Company, as well as other statements which are not historical facts. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will be achieved. By their nature, forward-looking statements involve many assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that predictions, forecasts, projections and other forward-looking statements will not be achieved. which may cause the performance and results of future periods to differ materially from any estimate or projection of future performance or results expressed or implied by such forward-looking statements. These assumptions, risks and uncertainties include, among other things, the state of the economy in general and the financial markets in particular, the interest of investors in the activities and future prospects of the Company.

The forward-looking statements contained in this press release are made as of the date of this press release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise forward-looking statements, whether as a result of new information, future events or otherwise, except as required. by applicable securities law. Further, the Company assumes no obligation to comment on any expectations or statements made by third parties with respect to the matters discussed above.